View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
  1. News
April 5, 2021

Advarra launches Accrual platform for clinical trials

US-based Advarra has launched Insights Accrual Prediction Platform, a new next-generation accrual prediction solution for clinical trials.

US-based Advarra has launched Insights Accrual Prediction Platform, a new next-generation accrual prediction solution for clinical trials.

Free Whitepaper
img

Unlocking the clinical trial potential of Africa

Ongoing improvements around infrastructure, continued investment, and being home to one of the world’s largest working age populations, means that Africa’s role in the clinical trials market has transformed. In this whitepaper, Oximio outlines the dynamics of today’s clinical trial market in Africa, including the key challenges the region is facing and how sponsors can overcome them to unlock the continent’s growing potential.
by Oximio
Enter your details here to receive your free Whitepaper.

Available through the Advarra Insights business intelligence platform, the new solution uses machine learning and predictive modelling to accurately estimate protocol accrual, strengthening clinical research success.

Built using a proprietary algorithm, it is planned to be initially launched to pilot customers as part of the Insights 2021R3 product release.

It allows clinical trial administrators to run hundreds of data points to analyse past accrual rates to make decision about which studies to activate, and also helps to predict the number of participants each study is likely to enrol.

The company noted that the new platform is part of the Advarra Insights business intelligence solution which is designed to quickly provide data-based answers to complex research questions.

University of Wisconsin Carbone Cancer Center Clinical Research assistant director Sarah Stewart said: “Unfortunately, resources to activate, open, and maintain clinical trials are limited and zero-accruing protocols are all too common.

“The Insights Accrual Prediction platform has the potential to be extremely valuable in preserving and redirecting precious resources towards successful trials.

“I look forward to the day when our organisation is regularly using the platform to make data-driven decisions to determine which trials to pursue, enabling us to focus on trials that will offer the most opportunity to our cancer patients.”

Advarra Insights synchronises the data by connecting to the customer’s OnCore Enterprise Research System CTMS environment to populate intuitive dashboards and reports.

This helps to identify areas required for intervention to provide a holistic showcase clinical research portfolio of organisation to internal and external leadership.

Related Companies

Free Whitepaper
img

Unlocking the clinical trial potential of Africa

Ongoing improvements around infrastructure, continued investment, and being home to one of the world’s largest working age populations, means that Africa’s role in the clinical trials market has transformed. In this whitepaper, Oximio outlines the dynamics of today’s clinical trial market in Africa, including the key challenges the region is facing and how sponsors can overcome them to unlock the continent’s growing potential.
by Oximio
Enter your details here to receive your free Whitepaper.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Key drug pipeline and competitive landscape changes based on the latest clinical activity, sent every Tuesday. Curated analysis and data-driven insights on clinical trials strategy and operations, sent every Thursday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Clinical Trials Arena